Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q3 FY25 results · Oct–Dec 2024
Advanced Enzyme Technologies reported revenue from operations of ₹169.11 crore (up 5.1% from Q3 FY24) and net profit of ₹38.88 crore (down 8.5% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 169.11 | 160.94 | +5.1% | 146.09 | +15.8% |
| Other income | 7.68 | 14.40 | −46.6% | 9.62 | −20.1% |
| Total income | 176.80 | 175.33 | +0.8% | 155.71 | +13.5% |
| Profit before tax | 53.02 | 58.88 | −9.9% | 42.21 | +25.6% |
| Net profit for the period | 38.88 | 42.50 | −8.5% | 33.39 | +16.4% |
| Attributable to shareholders of the company | 37.65 | 41.77 | −9.9% | 32.83 | +14.7% |
| EPS, basic (₹) | 3.36 | 3.74 | −10.2% | 2.94 | +14.3% |
| Net margin (%) | 23.0 | 26.4 | 22.9 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 100.87 | 91.14 | +10.7% | 77.38 | +30.4% |
| Other income | 1.43 | 3.56 | −59.9% | 1.66 | −13.7% |
| Total income | 102.30 | 94.71 | +8.0% | 79.03 | +29.4% |
| Profit before tax | 20.54 | 25.36 | −19.0% | 12.32 | +66.7% |
| Net profit for the period | 15.18 | 19.12 | −20.6% | 9.13 | +66.4% |
| EPS, basic (₹) | 1.36 | 1.71 | −20.5% | 0.82 | +65.9% |
| Net margin (%) | 15.1 | 21.0 | 11.8 |
Consolidated
- Filed with BSE
- 08 Feb 2025, 12:59 IST
- Board meeting
- 08 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Feb 2025, 12:59 IST
- Board meeting
- 08 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE